MLTX
Price
$9.70
Change
+$0.18 (+1.89%)
Updated
Oct 27, 11:37 AM (EDT)
Capitalization
604.53M
22 days until earnings call
Intraday Buy/Sell Signals
RAPP
Price
$26.22
Change
+$0.29 (+1.12%)
Updated
Oct 27, 11:44 AM (EDT)
Capitalization
1.2B
10 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

MLTX vs RAPP

Header iconMLTX vs RAPP Comparison
Open Charts MLTX vs RAPPBanner chart's image
MoonLake Immunotherapeutics
Price$9.70
Change+$0.18 (+1.89%)
Volume$2.74K
Capitalization604.53M
Rapport Therapeutics
Price$26.22
Change+$0.29 (+1.12%)
Volume$2.78K
Capitalization1.2B
MLTX vs RAPP Comparison Chart in %
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MLTX vs. RAPP commentary
Oct 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MLTX is a Hold and RAPP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 27, 2025
Stock price -- (MLTX: $9.52 vs. RAPP: $25.93)
Brand notoriety: MLTX and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MLTX: 29% vs. RAPP: 36%
Market capitalization -- MLTX: $604.53M vs. RAPP: $1.2B
MLTX [@Biotechnology] is valued at $604.53M. RAPP’s [@Biotechnology] market capitalization is $1.2B. The market cap for tickers in the [@Biotechnology] industry ranges from $108.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MLTX’s FA Score shows that 1 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • MLTX’s FA Score: 1 green, 4 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, RAPP is a better buy in the long-term than MLTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MLTX’s TA Score shows that 5 TA indicator(s) are bullish while RAPP’s TA Score has 2 bullish TA indicator(s).

  • MLTX’s TA Score: 5 bullish, 5 bearish.
  • RAPP’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, MLTX is a better buy in the short-term than RAPP.

Price Growth

MLTX (@Biotechnology) experienced а +4.39% price change this week, while RAPP (@Biotechnology) price change was +3.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.97%. For the same industry, the average monthly price growth was +11.13%, and the average quarterly price growth was +63.98%.

Reported Earning Dates

MLTX is expected to report earnings on Nov 18, 2025.

RAPP is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+0.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPP($1.2B) has a higher market cap than MLTX($605M). RAPP YTD gains are higher at: 46.167 vs. MLTX (-82.419). RAPP has higher annual earnings (EBITDA): -100.79M vs. MLTX (-196.98M). MLTX has more cash in the bank: 425M vs. RAPP (260M). RAPP has less debt than MLTX: RAPP (11.9M) vs MLTX (75.8M). MLTX (0) and RAPP (0) have equivalent revenues.
MLTXRAPPMLTX / RAPP
Capitalization605M1.2B51%
EBITDA-196.98M-100.79M195%
Gain YTD-82.41946.167-179%
P/E RatioN/A21.61-
Revenue00-
Total Cash425M260M163%
Total Debt75.8M11.9M637%
TECHNICAL ANALYSIS
Technical Analysis
MLTXRAPP
RSI
ODDS (%)
Bullish Trend 4 days ago
50%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
53%
Bearish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
61%
Bearish Trend 4 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
58%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 15 days ago
82%
Bullish Trend 7 days ago
90%
Declines
ODDS (%)
Bearish Trend 11 days ago
72%
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
78%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
MLTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAGCX61.010.79
+1.31%
Janus Henderson Glb Tech and Innovt C
HDPMX84.480.58
+0.69%
Hodges Retail
LYFCX14.200.05
+0.35%
AlphaCentric Life Sciences & Hlthcare C
TRPBX26.470.08
+0.30%
T. Rowe Price Spectrum Moderate Allc Inv
PNRCX49.460.11
+0.22%
PGIM Jennison Natural Resources C

MLTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MLTX has been closely correlated with KALA. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if MLTX jumps, then KALA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MLTX
1D Price
Change %
MLTX100%
+0.63%
KALA - MLTX
88%
Closely correlated
+1.75%
IOBT - MLTX
76%
Closely correlated
N/A
NEVPF - MLTX
70%
Closely correlated
N/A
XNCR - MLTX
50%
Loosely correlated
+7.05%
NUVL - MLTX
48%
Loosely correlated
+2.75%
More

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with NEVPF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
-0.99%
NEVPF - RAPP
45%
Loosely correlated
N/A
PRAX - RAPP
35%
Loosely correlated
-2.27%
FTRE - RAPP
35%
Loosely correlated
+4.63%
MLTX - RAPP
34%
Loosely correlated
+0.63%
DNTH - RAPP
32%
Poorly correlated
-1.05%
More